Keywords : Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN); Peptide Innovation for Early Diabetes Treatment (PIONEER); Semaglutide Treatment Effect in People with Obesity (STEP); Sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC); Rybelsus